134 related articles for article (PubMed ID: 10946092)
1. Comparison of the effect of histidine-rich glycoprotein and 6-aminohexanoic acid on plasmin production and fibrinolysis in vitro.
Horne MK; Goad JL; Merryman PK; Cullinane AM
Thromb Res; 2000 Jul; 99(2):179-86. PubMed ID: 10946092
[TBL] [Abstract][Full Text] [Related]
2. Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.
Aoki N; Moroi M; Tachiya K
Thromb Haemost; 1978 Feb; 39(1):22-31. PubMed ID: 77050
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
Angles-Cano E; Rouy D; Lijnen HR
Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
[TBL] [Abstract][Full Text] [Related]
4. Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding.
Rahman MN; Petrounevitch V; Jia Z; Koschinsky ML
Protein Eng; 2001 Jun; 14(6):427-38. PubMed ID: 11477223
[TBL] [Abstract][Full Text] [Related]
5. Poly-L-histidine downregulates fibrinolysis.
Chu AJ; Mathews ST
Blood Coagul Fibrinolysis; 2003 Oct; 14(7):627-32. PubMed ID: 14517486
[TBL] [Abstract][Full Text] [Related]
6. An analysis of mechanisms underlying the antifibrinolytic properties of radiographic contrast agents.
Farrehi PM; Zhu Y; Fay WP
J Thromb Thrombolysis; 2001 Dec; 12(3):273-81. PubMed ID: 11981110
[TBL] [Abstract][Full Text] [Related]
7. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
[TBL] [Abstract][Full Text] [Related]
8. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
Sugiyama N; Iwamoto M; Abiko Y
Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
Edelberg JM; Pizzo SV
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
[TBL] [Abstract][Full Text] [Related]
10. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
Anonick PK; Vasudevan J; Gonias SL
Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
[TBL] [Abstract][Full Text] [Related]
11. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
Longstaff C
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
[TBL] [Abstract][Full Text] [Related]
12. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolytic cross-talk: a new mechanism for plasmin formation.
Dejouvencel T; Doeuvre L; Lacroix R; Plawinski L; Dignat-George F; Lijnen HR; Anglés-Cano E
Blood; 2010 Mar; 115(10):2048-56. PubMed ID: 19996088
[TBL] [Abstract][Full Text] [Related]
14. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
de Haan J; van Oeveren W
Thromb Res; 1998 Nov; 92(4):171-9. PubMed ID: 9840026
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of plasmin activity by oleic acid.
Higazi AA; Finci-Yeheskel Z; Samara AA; Aziza R; Mayer M
Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):863-6. PubMed ID: 1532491
[TBL] [Abstract][Full Text] [Related]
16. The effect of fibrinogen degradation products and some lysine analogues on the dissociation of plasmin(ogen)-fibrin complexes.
Cederholm-Williams SA; Swain A
Thromb Res; 1979; 16(5-6):705-13. PubMed ID: 160626
[No Abstract] [Full Text] [Related]
17. Annexin II tetramer inhibits plasmin-dependent fibrinolysis.
Choi KS; Ghuman J; Kassam G; Kang HM; Fitzpatrick SL; Waisman DM
Biochemistry; 1998 Jan; 37(2):648-55. PubMed ID: 9425087
[TBL] [Abstract][Full Text] [Related]
18. Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-sepharose, and fibrin cleaved by plasmin.
Bok RA; Mangel WF
Biochemistry; 1985 Jun; 24(13):3279-86. PubMed ID: 3161540
[TBL] [Abstract][Full Text] [Related]
19. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
Urano S; Metzger AR; Castellino FJ
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
[TBL] [Abstract][Full Text] [Related]
20. Histidine-rich glycoprotein and alpha 2-plasmin inhibitor in inhibition of plasminogen binding to fibrin.
Ichinose A; Mimuro J; Koide T; Aoki N
Thromb Res; 1984 Feb; 33(4):401-7. PubMed ID: 6710439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
